World Anti-Inflammatory Therapeutics - Analysis of the Current Market and Estimations During 2014 - 2020

Aug 07, 2015, 07:10 ET from Research and Markets

DUBLIN, Aug. 7, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/qhvzwh/world) has announced the addition of the "World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 - 2020" report to their offering.

Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD). According to World Health Organization (WHO), approximately 235 million people suffer from asthma in the world.

The global anti-inflammatory therapeutics market is expected to grow at a CAGR of 5.9% over the forecast period, owing to the emergence of anti-inflammatory biologics that are more targeted, effective and with lesser side effects as compared to conventional drugs. In addition, they are also difficult to imitate due to their complex molecular structure and origin.

KEY MARKET BENEFITS:

  • The report provides a quantitative analysis of the current market and estimations during 2014 - 2020 that assist in identifying the prevailing market opportunities to capitalize.
  • Exhaustive analysis of the global anti-inflammatory therapeutics market by product type helps in understanding the types of therapeutics that are currently being used along with the categories that would gain prominence in the future.
  • Competitive intelligence (of leading manufacturers and distributors of anti-inflammatory therapeutics) helps in understanding the competitive scenario across the geographies.
  • Comprehensive analysis of factors that drive and restrict the growth of the global anti-inflammatory therapeutics market is provided

Companies Mentioned

  • - Abbvie
  • - Amgen
  • - AstraZeneca PLC
  • - Eli Lily and Company
  • - F. Hoffman
  • - GlaxoSmithKline
  • - Johnson & Johnson
  • - La Roche AG
  • - Merck & CO.
  • - Novartis
  • - Pfizer

Key Topics Covered:

Chapter: 1 REPORT DESCRIPTION

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 MARKET OVERVIEW

Chapter: 4 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY INDICATION

Chapter: 5 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS

Chapter: 6 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY

Chapter: 7 COMPANY PROFILES

For more information visit http://www.researchandmarkets.com/research/qhvzwh/world

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com